Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization

Abstract Background TP53 mutation is present in about 50.8% of lung adenocarcinomas, frequently in combination with other genetic alterations. However, a rare subset harbors the TP53 mutation alone. Methods Next‐generation sequencing was performed in 844 lung adenocarcinomas diagnosed by fine needle...

Full description

Bibliographic Details
Main Authors: Rachelle P. Mendoza, Heather I‐Hsuan Chen‐Yost, Pankhuri Wanjari, Peng Wang, Emily Symes, Daniel N. Johnson, Ward Reeves, Jeffrey Mueller, Tatjana Antic, Anna Biernacka
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.6873